SCPS Stock - Scopus BioPharma Inc.
Unlock GoAI Insights for SCPS
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-11,714,877 | $-27,634,619 | $-10,155,846 | $-2,689,948 | $-685,964 |
| Net Income | $-11,609,827 | $-27,728,088 | $-11,568,738 | $-2,689,949 | $-685,964 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.55 | $-1.61 | $-0.87 | $-0.18 | $-0.05 |
Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) inhibitors; and MRI-1867, rationally designed, orally available, dual-action, hybrid, and small molecule that is an inverse agonist of the endocannabinoid system/cannabinoid receptor 1, as well as an inhibitor of inducible nitric oxide synthase. Scopus BioPharma Inc. has strategic partnerships with the City of Hope, National Institutes of Health Program, and The Hebrew University of Jerusalem for its lead development and other programs. The company was formerly known as Project18 Inc. and changed its name to Scopus BioPharma Inc. in December 2017. Scopus BioPharma Inc. was incorporated in 2017 and is headquartered in New York, New York.
Visit WebsiteEarnings History & Surprises
SCPSEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2023 | Aug 11, 2023 | — | $-0.07 | — | — |
Q2 2023 | May 12, 2023 | — | $-0.08 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.08 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.09 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.16 | — | — |
Q2 2022 | Apr 15, 2022 | — | $-0.22 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.38 | — | — |
Q4 2021 | Nov 12, 2021 | $-0.23 | $-0.08 | +65.2% | ✓ BEAT |
Q3 2021 | Aug 13, 2021 | $-0.23 | $-0.97 | -321.7% | ✗ MISS |
Q2 2021 | May 17, 2021 | $-0.08 | $-0.22 | -175.0% | ✗ MISS |
Q1 2021 | Jan 28, 2021 | — | $-0.08 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.08 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.54 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.04 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.06 | — | — |
Q3 2019 | Sep 30, 2019 | — | $-0.05 | — | — |
Q1 2019 | Mar 31, 2019 | — | $-0.03 | — | — |
Q1 2018 | Mar 31, 2018 | — | $-0.01 | — | — |
Latest News
Frequently Asked Questions about SCPS
What is SCPS's current stock price?
What is the analyst price target for SCPS?
What sector is Scopus BioPharma Inc. in?
What is SCPS's market cap?
Does SCPS pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to SCPS for comparison